Enliven Therapeutics
ELVNInsider trades and stock quote 2024-2026
All insider trades at Enliven Therapeutics
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 7/17/2026 | Sell | Collins, Helen Louise | CHIEF MEDICAL OFFICER | $52.3 | $263,374 |
| 7/17/2026 | Sell | Hohl, Benjamin | CHIEF FINANCIAL OFFICER | $52.2 | $316,780 |
| 7/6/2026 | Sell | Kunkel, Lori Anne | Director | $50.4 | $504,903 |
| 6/22/2026 | Sell | Orbimed Advisors LLC | Ten Percent Owner | $45.2 | $39,014,045 |
| 6/17/2026 | Sell | Collins, Helen Louise | CHIEF MEDICAL OFFICER | $43.8 | $219,017 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)